Walgreens offers H1N1 vaccine in 27 states

NewsGuard 100/100 Score

Walgreens (NYSE, NASDAQ: WAG), the nation’s largest drugstore chain and an industry leader with more than 17,000 certified or licensed immunizers, today announced it is offering H1N1 vaccine at more than 1,500 Walgreens pharmacies and select Take Care Clinics in 27 states, as well as the District of Columbia. Walgreens continues to work with government agencies in the 23 other U.S. states to receive and distribute H1N1 vaccine, and to serve as a strategic distribution partner in communities nationwide. Walgreens plans to be offering H1N1 vaccine in all 50 states by the end of December.

Walgreens and Take Care Clinics had been administering H1N1 vaccine in select markets to only those within the priority groups as outlined by the Centers for Disease Control and Prevention (CDC). However as more states, public health departments and local governments are now lifting vaccination restrictions, Walgreens is able to offer H1N1 vaccine to anyone who wants a vaccination and who meets state age requirements, in 27 states. To date, Walgreens and Take Care Clinics have administered more than 200,000 H1N1 vaccinations.

Source Walgreens

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study rethinks immune system strategies to boost vaccine effectiveness